Why is Eiko Lifescience falling/rising?

As of 23-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 54.22, reflecting a decrease of Rs 3.48 or 6.03%. Today's performance indicates that the stock has underperformed its sector by 6.57%, with an intraday low of Rs 53.15, marking a drop of 7.89%. Over the past week, the stock has shown a slight gain of 0.58%, but it has significantly underperformed over the longer term, with a year-to-date decline of 13.58% and a one-year drop of 16.12%. Despite a recent increase in promoter confidence, with a 4.96% rise in their stake, the company faces challenges such as weak long-term fundamentals, evidenced by a low return on equity of 2.82% and a significant drop in net sales of 15.60% in the last quarter.
In the broader market context, while the Sensex has shown a modest gain of 0.11% over the past week, Eiko Lifesciences' short-term performance is notably better than its long-term trajectory, where it has lagged behind the benchmark indices. The stock's performance over the last three years has been particularly poor, with a return of only 26.39% compared to the Sensex's 47.54%. This underperformance, combined with the company's flat results and high valuation metrics, contributes to a negative outlook, reinforcing the perception of the stock as a strong sell despite the recent uptick in investor participation.